Market Tracker

07/28 6:01pm ET

Valeant Pharmaceuticals International Inc (NYSE:VRX)

During the Trading Day
257.95 +0.65 / +0.25%
As of 4:01pm ET
Day’s Change
During After-Hours   Switch to standard view »
256.11 -1.84 / -0.71%
 
Volume: 16.4K

Today’s Trading

Previous close257.30
Today’s open259.83
Day’s range255.70 - 259.99
Volume1,853,808
Average volume (3 months)1,709,411
Market cap$87.8B
Dividend yield--
Data as of 4:01pm ET, 07/28/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+38.88%
Earnings growth (next 5 years)+28.79%
Revenue growth (last year)+43.22%
P/E ratio96.4
Price/Sales5.93
Price/Book16.20

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca+0.10+0.31%
LLYEli Lilly and Co+1.53+1.82%
ABTAbbott Laboratories+0.25+0.49%
GSKGlaxoSmithKline+0.11+0.26%
Data as of 4:04pm ET, 07/28/2015

Financials

Next reporting dateNovember 5, 2015
EPS forecast (this quarter)$2.71
Annual revenue (last year)$8.3B
Annual profit (last year)$913.5M
Net profit margin11.05%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
J. Michael Pearson
Chief Financial Officer &
Executive Vice President
Robert L. Rosiello
Corporate headquarters
Laval, Quebec

Forecasts